The NICE guideline on prostate cancer recommends that a multiparametric MRI test should be offered to people with suspected clinically localised prostate cancer. People with a significant lesion ...

Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...

Enhanced Detection of Druggable Mutations in Non–Small Cell Lung Cancer Using Targeted Collection of Bronchial Washing Fluid Compared With Plasma and Tumor Tissue Our study found that PZ biopsies ...

Prostate-specific antigen (PSA) screening aims to identify men who may harbor potentially lethal prostate cancer, and those with high PSA results often require more extensive (and expensive) ...

GRENOBLE, France and PRINCETON, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in MRI-ultrasound fusion guidance for prostate ...

Seven years after the activation of the prostate biopsy service using Fusion technology, one of the most advanced innovations internationally for combating prostate cancer, the 'San Michele' Clinic in ...

American researchers have developed a urine test showing promise in prostate cancer detection, potentially reducing the need for painful biopsies. The test identifies three biomarkers—TTC3, H4C5, and ...

Forbes contributors publish independent expert analyses and insights. Bruce Y. Lee, M.D., MBA, covers health, medicine, wellness and science International Tennis Hall-of-Famer Björn Borg serves up ...